ArticleJournal of cancer research and clinical oncology2022

Carboplatin and nab-paclitaxel chemotherapy with or without atezolizumab as front-line management for treatment-naïve metastatic nonsquamous non-small cell lung cancer with PD-L1 staining: a retrospective study.

Bo Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.